Cargando…

CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy

The benefits of CAR-T therapy could be expanded to the treatment of solid tumors through the use of derived autologous αβ T cell, but clinical trials of CAR-T therapy for patients with solid tumors have so far been disappointing. CAR-T therapy also faces hurdles due to the time and cost intensive pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yizheng, Wang, Linan, Seo, Naohiro, Okumura, Satoshi, Hayashi, Tae, Akahori, Yasushi, Fujiwara, Hiroshi, Amaishi, Yasunori, Okamoto, Sachiko, Mineno, Junichi, Tanaka, Yoshimasa, Kato, Takuma, Shiku, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341429/ https://www.ncbi.nlm.nih.gov/pubmed/37446055 http://dx.doi.org/10.3390/ijms241310873

Ejemplares similares

Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome
por: Wang, Linan, et al.
Publicado: (2016)

Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells
por: Sato, Osamu, et al.
Publicado: (2023)

A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression
por: Okamoto, Sachiko, et al.
Publicado: (2012)

Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells
por: Okuno, Daisuke, et al.
Publicado: (2020)

Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs
por: Okamoto, Sachiko, et al.
Publicado: (2019)

αβ-T cell receptor transduction gives superior mitochondrial function to γδ-T cells with promising persistence
por: Ishihara, Mikiya, et al.
Publicado: (2023)

Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug
por: Tanaka, Yoshimasa, et al.
Publicado: (2018)

Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug
por: Tanaka, Yoshimasa, et al.
Publicado: (2017)

Prodrugs of pyrophosphates and bisphosphonates: disguising phosphorus oxyanions
por: Rudge, Emma S., et al.
Publicado: (2022)

A Functionally Superior Second-Generation Vector Expressing an Aurora Kinase-A-Specific T-Cell Receptor for Anti-Leukaemia Adoptive Immunotherapy
por: Casey, Nicholas Paul, et al.
Publicado: (2016)

T cell receptor gene‐modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft‐versus‐host disease
por: Okada, Satomi, et al.
Publicado: (2023)

Systemic CD8(+) T Cell-Mediated Tumoricidal Effects by Intratumoral Treatment of Oncolytic Herpes Simplex Virus with the Agonistic Monoclonal Antibody for Murine Glucocorticoid-Induced Tumor Necrosis Factor Receptor
por: Ishihara, Mikiya, et al.
Publicado: (2014)

Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression
por: Ikeda, Hiroaki, et al.
Publicado: (2014)

Guanine-Rich Sequences Are a Dominant Feature of Exosomal microRNAs across the Mammalian Species and Cell Types
por: Momose, Fumiyasu, et al.
Publicado: (2016)

Combining Vγ9Vδ2 T Cells with a Lipophilic Bisphosphonate Efficiently Kills Activated Hepatic Stellate Cells
por: Zhou, Xiaoying, et al.
Publicado: (2017)

Co-Introduced Functional CCR2 Potentiates In Vivo Anti-Lung Cancer Functionality Mediated by T Cells Double Gene-Modified to Express WT1-Specific T-Cell Receptor
por: Asai, Hiroaki, et al.
Publicado: (2013)

Genetic engineering of T cells with receptors from NY-ESO-1-specific tumor-recognizing CD4+ T cell as a novel approach for adoptive T cell therapy
por: Matsuzaki, Junko, et al.
Publicado: (2015)

Aryloxy Diester Phosphonamidate Prodrugs of Phosphoantigens (ProPAgens) as Potent Activators of Vγ9/Vδ2 T-Cell Immune Responses
por: Kadri, Hachemi, et al.
Publicado: (2020)

Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4
por: Alsalloum, Alaa, et al.
Publicado: (2023)

Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction
por: Hayashi, Hiroki, et al.
Publicado: (2023)

Exosome‐mediated regulation of tumor immunology
por: Seo, Naohiro, et al.
Publicado: (2018)

Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses
por: Matsuzaki, Junko, et al.
Publicado: (2015)

Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant
por: Hayashi, Hiroki, et al.
Publicado: (2022)

Co-Expansion of Cytokine-Induced Killer Cells and Vγ9Vδ2 T Cells for CAR T-Cell Therapy
por: Du, Shou-Hui, et al.
Publicado: (2016)

Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury
por: Asai, Hiroaki, et al.
Publicado: (2014)

Preclinical study of a DNA vaccine targeting SARS-CoV-2
por: Hayashi, Hiroki, et al.
Publicado: (2022)

Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation
por: Nada, Mohanad H., et al.
Publicado: (2017)

Administration of bisphosphonate for hypercalcemia associated with oral cancer
por: Onizawa, Kojiro, et al.
Publicado: (2006)

Electroporation of NKG2D RNA CAR Improves Vγ9Vδ2 T Cell Responses against Human Solid Tumor Xenografts
por: Ang, Wei Xia, et al.
Publicado: (2020)

A Simple and Robust Single-Step Method for CAR-Vδ1 γδT Cell Expansion and Transduction for Cancer Immunotherapy
por: Ferry, Gabrielle M., et al.
Publicado: (2022)

Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity
por: Kabelitz, Dieter, et al.
Publicado: (2013)

PD-1 checkpoint blockade enhances adoptive immunotherapy by human Vγ2Vδ2 T cells against human prostate cancer
por: Nada, Mohanad H., et al.
Publicado: (2021)

Evidence for an Adult-Like Type 1-Immunity Phenotype of Vδ1, Vδ2 and Vδ3 T Cells in Ghanaian Children With Repeated Exposure to Malaria
por: León-Lara, Ximena, et al.
Publicado: (2022)

Optical Flow-Based Analysis of the Relationships between Leaf Wilting and Stem Diameter Variations in Tomato Plants
por: Wakamori, Kazumasa, et al.
Publicado: (2019)

Development of a Δ(9)-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
por: Adelli, Goutham R., et al.
Publicado: (2017)

Synthesis and Biological Evaluation of (E)-4-Hydroxy-3-methylbut-2-enyl Phosphate (HMBP) Aryloxy Triester Phosphoramidate Prodrugs as Activators of Vγ9/Vδ2 T-Cell Immune Responses
por: Davey, Martin S., et al.
Publicado: (2018)

Cancer immunotherapy; integration of T cell biology with nanogel- and vector-technology in translational research
por: Shiku, Hiroshi
Publicado: (2012)

Clinical remission of an inoperable malignant insulinoma by the combination treatment with octreotide and everolimus
por: Akahori, Hiroshi
Publicado: (2019)

In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer
por: Ikeda, Hiroaki, et al.
Publicado: (2013)

Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants
por: Teli, Divya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tqokb12b6phh5ida347qir29i1